Rani Therapeutics Ownership 2024 | Who Owns Rani Therapeutics Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

3.97%

Insider Ownership

43.90%

Retail Ownership

52.14%

Institutional Holders

15.00

Rani Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	2.73%	0.00%	709,828	24,525	3.58%	2,697,347	Jun 30, 2024
NAN FUNG GROUP HOLDINGS LTD	1.90%	2.00%	493,584	-	-	1,875,619	Jun 30, 2024
ALPHABET INC.	1.72%	0.09%	448,492	-	-	1,704,270	Jun 30, 2024
UNITED SERVICES AUTOMOBILE ASSOCIATION	1.20%	0.03%	312,095	-169,205	-35.16%	1,185,961	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.58%	0.00%	150,734	19,828	15.15%	572,922	Jun 30, 2024
STIFEL FINANCIAL CORP	0.52%	0.00%	134,620	2,186	1.65%	511,556	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.35%	-	91,846	-32,659	-26.23%	349,015	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.27%	0.01%	71,500	20,000	38.84%	271,700	Jun 30, 2024
BLACKROCK INC.	0.24%	-	63,583	-	-	241,615	Jun 30, 2024
LASRY MARC	0.24%	0.24%	62,887	-	-	238,971	Jun 30, 2024
KING LUTHER CAPITAL MANAGEMENT CORP	0.22%	0.00%	56,129	-	-	213,290	Jun 30, 2024
MOTCO	0.18%	0.01%	48,129	-	-	182,890	Jun 30, 2024
STATE STREET CORP	0.16%	-	42,042	8,300	24.60%	159,760,000	Jun 30, 2024
NORTHERN TRUST CORP	0.14%	-	35,306	9,318	35.85%	134,163,000	Jun 30, 2024
BROWN ADVISORY INC	0.13%	0.00%	32,911	-1,000	-2.95%	125,062	Jun 30, 2024
BELVEDERE TRADING LLC	0.12%	0.00%	30,800	30,800	100.00%	117,040	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.08%	0.00%	21,700	-48,600	-69.13%	82,460	Jun 30, 2024
MARSHALL WACE, LLP	0.08%	0.00%	21,247	21,247	100.00%	80,739	Jun 30, 2024
LAFAYETTE INVESTMENTS, INC.	0.08%	0.02%	19,893	-	-	75,594	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.06%	0.00%	14,437	13,198	1065.21%	54,861	Jun 30, 2024

Rani Therapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 2.73% of the company's total share outstanding, currently valued at $2.70M. The top 10 institutional shareholders own together 9.75% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
NAN FUNG GROUP HOLDINGS LTD	1.90%	2.00%	493,584	-	-	1,875,619	Jun 30, 2024
LASRY MARC	0.24%	0.24%	62,887	-	-	238,971	Jun 30, 2024
ALPHABET INC.	1.72%	0.09%	448,492	-	-	1,704,270	Jun 30, 2024
UNITED SERVICES AUTOMOBILE ASSOCIATION	1.20%	0.03%	312,095	-169,205	-35.16%	1,185,961	Jun 30, 2024
ISLAY CAPITAL MANAGEMENT, LLC	0.04%	0.03%	9,611	-	-	36,522	Jun 30, 2024
LAFAYETTE INVESTMENTS, INC.	0.08%	0.02%	19,893	-	-	75,594	Jun 30, 2024
MOTCO	0.18%	0.01%	48,129	-	-	182,890	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.27%	0.01%	71,500	20,000	38.84%	271,700	Jun 30, 2024
VIRTU FINANCIAL LLC	0.04%	0.00%	10,153	10,153	100.00%	39,000	Jun 30, 2024
KING LUTHER CAPITAL MANAGEMENT CORP	0.22%	0.00%	56,129	-	-	213,290	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.06%	0.00%	14,437	13,198	1065.21%	54,861	Jun 30, 2024
PRIME CAPITAL INVESTMENT ADVISORS, LLC	0.05%	0.00%	13,882	-	-	52,752	Jun 30, 2024
STIFEL FINANCIAL CORP	0.52%	0.00%	134,620	2,186	1.65%	511,556	Jun 30, 2024
BROWN ADVISORY INC	0.13%	0.00%	32,911	-1,000	-2.95%	125,062	Jun 30, 2024
BELVEDERE TRADING LLC	0.12%	0.00%	30,800	30,800	100.00%	117,040	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.08%	0.00%	21,700	-48,600	-69.13%	82,460	Jun 30, 2024
MARSHALL WACE, LLP	0.08%	0.00%	21,247	21,247	100.00%	80,739	Jun 30, 2024
ALLWORTH FINANCIAL LP	0.01%	0.00%	3,119	-	-	9,607	Jun 30, 2024
VANGUARD GROUP INC	2.73%	0.00%	709,828	24,525	3.58%	2,697,347	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.58%	0.00%	150,734	19,828	15.15%	572,922	Jun 30, 2024

The largest Rani Therapeutics shareholder by % of total assets is NAN FUNG GROUP HOLDINGS LTD. The company owns 493.58K shares of Rani Therapeutics (RANI), representing 2.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BELVEDERE TRADING LLC	0.12%	0.00%	30,800	30,800	100.00%	117,040	Jun 30, 2024
VANGUARD GROUP INC	2.73%	0.00%	709,828	24,525	3.58%	2,697,347	Jun 30, 2024
MARSHALL WACE, LLP	0.08%	0.00%	21,247	21,247	100.00%	80,739	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.27%	0.01%	71,500	20,000	38.84%	271,700	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.58%	0.00%	150,734	19,828	15.15%	572,922	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.06%	0.00%	14,437	13,198	1065.21%	54,861	Jun 30, 2024
VIRTU FINANCIAL LLC	0.04%	0.00%	10,153	10,153	100.00%	39,000	Jun 30, 2024
NORTHERN TRUST CORP	0.14%	-	35,306	9,318	35.85%	134,163,000	Jun 30, 2024
STATE STREET CORP	0.16%	-	42,042	8,300	24.60%	159,760,000	Jun 30, 2024
STIFEL FINANCIAL CORP	0.52%	0.00%	134,620	2,186	1.65%	511,556	Jun 30, 2024
BELVEDERE TRADING LLC	0.00%	-	1,100	1,100	100.00%	4,180	Jun 30, 2024
BELVEDERE TRADING LLC	0.00%	-	991	991	100.00%	3,766	Jun 30, 2024
MORGAN STANLEY	0.01%	-	2,951	500	20.40%	11,214	Jun 30, 2024
SIMPLEX TRADING, LLC	0.01%	-	1,482	118	8.65%	5,000	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	-	-	3	-	-	12	Jun 30, 2024
RHUMBLINE ADVISERS	0.00%	-	312	-	-	1,185	Jun 30, 2024
UBS GROUP AG	0.01%	-	3,000	-	-	11,400	Jun 30, 2024
BLACKROCK INC.	0.24%	-	63,583	-	-	241,615	Jun 30, 2024
ALLWORTH FINANCIAL LP	0.01%	0.00%	3,119	-	-	9,607	Jun 30, 2024
PRIME CAPITAL INVESTMENT ADVISORS, LLC	0.05%	0.00%	13,882	-	-	52,752	Jun 30, 2024

As of Jun 30 2024, Rani Therapeutics's largest institutional buyer is BELVEDERE TRADING LLC. The company purchased 30.80K stocks of RANI, valued at $117.04K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UNITED SERVICES AUTOMOBILE ASSOCIATION	1.20%	0.03%	312,095	-169,205	-35.16%	1,185,961	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.08%	0.00%	21,700	-48,600	-69.13%	82,460	Jun 30, 2024
ALPHA SQUARE GROUP S, LLC	-	-	-	-33,401	-100.00%	-	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.35%	-	91,846	-32,659	-26.23%	349,015	Jun 30, 2024
XR SECURITIES LLC	-	-	-	-30,900	-100.00%	-	Jun 30, 2024
HRT FINANCIAL LP	-	-	-	-22,587	-100.00%	-	Jun 30, 2024
CHOREO, LLC	-	-	-	-19,813	-100.00%	-	Jun 30, 2024
JPMORGAN CHASE & CO	0.00%	-	71	-12,615	-99.44%	270	Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT	-	-	-	-9,800	-100.00%	-	Jun 30, 2024
PNC FINANCIAL SERVICES GROUP, INC.	0.01%	-	2,000	-7,116	-78.06%	7,600	Jun 30, 2024
BROWN ADVISORY INC	0.13%	0.00%	32,911	-1,000	-2.95%	125,062	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-103	-100.00%	-	Jun 30, 2024
NAN FUNG GROUP HOLDINGS LTD	1.90%	2.00%	493,584	-	-	1,875,619	Jun 30, 2024
LASRY MARC	0.24%	0.24%	62,887	-	-	238,971	Jun 30, 2024
ALPHABET INC.	1.72%	0.09%	448,492	-	-	1,704,270	Jun 30, 2024
ISLAY CAPITAL MANAGEMENT, LLC	0.04%	0.03%	9,611	-	-	36,522	Jun 30, 2024
LAFAYETTE INVESTMENTS, INC.	0.08%	0.02%	19,893	-	-	75,594	Jun 30, 2024
MOTCO	0.18%	0.01%	48,129	-	-	182,890	Jun 30, 2024
KING LUTHER CAPITAL MANAGEMENT CORP	0.22%	0.00%	56,129	-	-	213,290	Jun 30, 2024
PRIME CAPITAL INVESTMENT ADVISORS, LLC	0.05%	0.00%	13,882	-	-	52,752	Jun 30, 2024

As of Jun 30 2024, Rani Therapeutics's biggest institutional seller is UNITED SERVICES AUTOMOBILE ASSOCIATION. The company sold -0.17M shares of RANI, valued at $1.19M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BELVEDERE TRADING LLC	0.12%	0.00%	30,800	30,800	100.00%	117,040	Jun 30, 2024
MARSHALL WACE, LLP	0.08%	0.00%	21,247	21,247	100.00%	80,739	Jun 30, 2024
VIRTU FINANCIAL LLC	0.04%	0.00%	10,153	10,153	100.00%	39,000	Jun 30, 2024
BELVEDERE TRADING LLC	0.00%	-	1,100	1,100	100.00%	4,180	Jun 30, 2024
BELVEDERE TRADING LLC	0.00%	-	991	991	100.00%	3,766	Jun 30, 2024

Rani Therapeutics's largest new institutional shareholder by number of shares is BELVEDERE TRADING LLC, purchased 30.80K shares, valued at $117.04K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ALPHA SQUARE GROUP S, LLC	-	-	-	-33,401	-100.00%	-	Jun 30, 2024
XR SECURITIES LLC	-	-	-	-30,900	-100.00%	-	Jun 30, 2024
HRT FINANCIAL LP	-	-	-	-22,587	-100.00%	-	Jun 30, 2024
CHOREO, LLC	-	-	-	-19,813	-100.00%	-	Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT	-	-	-	-9,800	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-103	-100.00%	-	Jun 30, 2024

Rani Therapeutics's largest sold out institutional shareholder by shares sold is ALPHA SQUARE GROUP S, LLC, sold -33.40K shares, valued at -, as of undefined.

Rani Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD VALLEY FORGE FUNDS	0.03%	17,809	-	-	Mar 31, 2024
BRIDGEWAY FUNDS INC	0.02%	51,500	-	-	Mar 28, 2024
VANGUARD INDEX FUNDS	0.00%	667,153	-78,921	-10.58%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	124,026	16,753	15.62%	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	14,248	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	2,793	-	-	Feb 29, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	3,944	3,944	-	Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	280	-	-	Mar 31, 2024
Goldman Sachs ETF Trust	0.00%	2,119	-	-	Feb 29, 2024
PROSHARES TRUST	0.00%	2,060	-	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,880	-	-	Jan 31, 2024
iSHARES TRUST	0.00%	127,073	-	-	Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS	0.00%	3,926	-	-	Feb 29, 2024
Invesco Exchange-Traded Fund Trust II	0.00%	453	-	-	Jan 31, 2024
GOLDMAN SACHS TRUST	0.00%	4,103	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	594	-	-	Mar 31, 2024

Rani Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 17.81K shares, compromising 0.03% of its total assets.

Rani Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	15	-59.46%
31 Mar, 24	37	15.63%
31 Dec, 23	32	-3.03%
30 Sep, 23	33	-8.33%
30 Jun, 23	36	-2.70%
31 Mar, 23	37	8.82%
31 Dec, 22	34	6.25%
30 Sep, 22	32	18.52%
30 Jun, 22	27	17.39%
31 Mar, 22	23	9.52%
31 Dec, 21	21	40.00%
30 Sep, 21	15	-

As of 30 Jun 24, 15 institutions are holding Rani Therapeutics's shares, representing a decrease of -59.46% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	1,032,982	-66.84%
31 Mar, 24	3,115,105	5.54%
31 Dec, 23	2,951,624	-8.01%
30 Sep, 23	3,208,534	-0.58%
30 Jun, 23	3,227,286	7.60%
31 Mar, 23	2,999,366	1.73%
31 Dec, 22	2,948,381	-7.13%
30 Sep, 22	3,174,625	12.37%
30 Jun, 22	2,825,035	10.49%
31 Mar, 22	2,556,816	106.04%
31 Dec, 21	1,240,939	13.05%
30 Sep, 21	1,097,738	-

Rani Therapeutics (RANI) has 1.03M shares outstanding as of 30 Jun 24, down -66.84% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	3.97%	2.66%
31 Mar, 24	12.21%	9.15%
31 Dec, 23	11.55%	7.21%
30 Sep, 23	12.66%	7.74%
30 Jun, 23	12.79%	9.05%
31 Mar, 23	11.88%	8.48%
31 Dec, 22	11.84%	7.03%
30 Sep, 22	12.97%	9.66%
30 Jun, 22	11.59%	8.13%
31 Mar, 22	11.94%	29.30%
31 Dec, 21	6.38%	20.02%
30 Sep, 21	5.65%	-

As of 30 Jun 24, Rani Therapeutics is held by 3.97% institutional shareholders, representing a 2.66% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	4	-66.67%
31 Mar, 24	12	140.00%
31 Dec, 23	5	-44.44%
30 Sep, 23	9	-43.75%
30 Jun, 23	16	6.67%
31 Mar, 23	15	-
31 Dec, 22	15	-6.25%
30 Sep, 22	16	23.08%
30 Jun, 22	13	18.18%
31 Mar, 22	11	-26.67%
31 Dec, 21	15	-
30 Sep, 21	15	-

4 institutional shareholders have increased their position in RANI stock as of 30 Jun 24 compared to 12 in the previous quarter (a -66.67% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	3	-40.00%
31 Mar, 24	5	-16.67%
31 Dec, 23	6	-14.29%
30 Sep, 23	7	250.00%
30 Jun, 23	2	-50.00%
31 Mar, 23	4	-50.00%
31 Dec, 22	8	-
30 Sep, 22	8	33.33%
30 Jun, 22	6	-14.29%
31 Mar, 22	7	250.00%
31 Dec, 21	2	-
30 Sep, 21	-	-

3 institutional shareholders have reduced their position in RANI stock as of 30 Jun 24 compared to 5 in the previous quarter (a -40.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	15	-59.46%	1,032,982	-66.84%	3.97%	2.66%	4	-66.67%	3	-40.00%
31 Mar, 24	37	15.63%	3,115,105	5.54%	12.21%	9.15%	12	140.00%	5	-16.67%
31 Dec, 23	32	-3.03%	2,951,624	-8.01%	11.55%	7.21%	5	-44.44%	6	-14.29%
30 Sep, 23	33	-8.33%	3,208,534	-0.58%	12.66%	7.74%	9	-43.75%	7	250.00%
30 Jun, 23	36	-2.70%	3,227,286	7.60%	12.79%	9.05%	16	6.67%	2	-50.00%
31 Mar, 23	37	8.82%	2,999,366	1.73%	11.88%	8.48%	15	-	4	-50.00%
31 Dec, 22	34	6.25%	2,948,381	-7.13%	11.84%	7.03%	15	-6.25%	8	-
30 Sep, 22	32	18.52%	3,174,625	12.37%	12.97%	9.66%	16	23.08%	8	33.33%
30 Jun, 22	27	17.39%	2,825,035	10.49%	11.59%	8.13%	13	18.18%	6	-14.29%
31 Mar, 22	23	9.52%	2,556,816	106.04%	11.94%	29.30%	11	-26.67%	7	250.00%
31 Dec, 21	21	40.00%	1,240,939	13.05%	6.38%	20.02%	15	-	2	-
30 Sep, 21	15	-	1,097,738	-	5.65%	-	15	-	-	-

Rani Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 19, 2023	Sanford Svai S	officer	Chief Financial Officer	D-Return	Sell	83,724	$9.44	$790.35K	127,788
Dec 19, 2023	Sanford Svai S	officer	Chief Financial Officer	D-Return	Sell	58,334	$13.21	$770.59K	41,666
Dec 19, 2023	Sanford Svai S	officer	Chief Financial Officer	D-Return	Sell	171,500	$5.44	$932.96K	34,300
Dec 19, 2023	Hashim Mir	officer	Chief Scientific Officer	D-Return	Sell	83,724	$9.44	$790.35K	127,788

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 30, 2024	IMRAN MIR A	director	-	A-Award	Buy	50,000	$5.00	$250.00K	50,000
May 30, 2024	Farquharson Andrew	director	-	A-Award	Buy	50,000	$5.00	$250.00K	50,000
May 30, 2024	Nanavaty Maulik	director	-	A-Award	Buy	50,000	$5.00	$250.00K	50,000
May 30, 2024	DEBUONO LAUREEN	director	-	A-Award	Buy	50,000	$5.00	$250.00K	50,000
May 30, 2024	Ausiello Dennis A	director	-	A-Award	Buy	50,000	$5.00	$250.00K	50,000
May 30, 2024	Rometty Lisa Ann	director	-	A-Award	Buy	50,000	$5.00	$250.00K	50,000
May 30, 2024	BUTEL JEAN LUC	director	-	A-Award	Buy	50,000	$5.00	$250.00K	50,000
Mar 22, 2024	McKinley Kate	officer	Chief Business Officer	A-Award	Buy	323,500	$3.60	$1.16M	323,500
Mar 22, 2024	Hashim Mir	officer	Chief Scientific Officer	A-Award	Buy	323,500	$3.60	$1.16M	323,500
Mar 22, 2024	Groen Eric	officer	General Counsel	A-Award	Buy	323,500	$3.60	$1.16M	323,500
Mar 22, 2024	Imran Talat	director, officer	Chief Executive Officer	A-Award	Buy	1,085,000	$3.60	$3.91M	1,085,000
Mar 22, 2024	Sanford Svai S	officer	Chief Financial Officer	A-Award	Buy	323,500	$3.60	$1.16M	323,500
Dec 19, 2023	Sanford Svai S	officer	Chief Financial Officer	A-Award	Buy	171,500	$2.84	$487.06K	171,500
Dec 19, 2023	Sanford Svai S	officer	Chief Financial Officer	D-Return	Sell	83,724	$9.44	$790.35K	127,788
Dec 19, 2023	Sanford Svai S	officer	Chief Financial Officer	A-Award	Buy	83,724	$2.84	$237.78K	83,724
Dec 19, 2023	Sanford Svai S	officer	Chief Financial Officer	A-Award	Buy	58,334	$2.84	$165.67K	58,334
Dec 19, 2023	Sanford Svai S	officer	Chief Financial Officer	D-Return	Sell	58,334	$13.21	$770.59K	41,666
Dec 19, 2023	Sanford Svai S	officer	Chief Financial Officer	D-Return	Sell	171,500	$5.44	$932.96K	34,300
Dec 19, 2023	Hashim Mir	officer	Chief Scientific Officer	A-Award	Buy	171,500	$2.84	$487.06K	171,500
Dec 19, 2023	Hashim Mir	officer	Chief Scientific Officer	D-Return	Sell	83,724	$9.44	$790.35K	127,788

The last insider sell of Rani Therapeutics's stock was made by Sanford Svai S on Dec 19 2023, selling 83,724 shares at $9.44 per share (valued at $790.35K).

Rani Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	7	-	-
Q1 2024	5	-	-
Q4 2023	34	27	125.93%
Q3 2023	-	-	-
Q2 2023	27	-	-
Q1 2023	29	4	725.00%
Q4 2022	31	-	-
Q3 2022	2	4	50.00%
Q2 2022	10	-	-
Q1 2022	13	7	185.71%
Q4 2021	1	1	100.00%
Q3 2021	6	36	16.67%

7 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Rani Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q1 2024	-	-	-
Q4 2023	8	1	800.00%
Q3 2023	-	-	-
Q2 2023	19	-	-
Q1 2023	21	-	-
Q4 2022	31	-	-
Q3 2022	-	2	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-
Q3 2021	3	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Rani Therapeutics's stocks.

Rani Therapeutics Peer Ownership

Ticker	Company
PMVP	PMV Pharmaceuticals, Inc.
MNPR	Monopar Therapeutics Inc.
EYPT	EyePoint Pharmaceuticals, Inc.
BMEA	Biomea Fusion, Inc.
TNYA	Tenaya Therapeutics, Inc.
CRVS	Corvus Pharmaceuticals, Inc.
SRZN	Surrozen, Inc.
ALXO	ALX Oncology Holdings Inc.
SQZ	SQZ Biotechnologies Company
VIRX	Viracta Therapeutics, Inc.
TYRA	Tyra Biosciences, Inc.
CABA	Cabaletta Bio, Inc.
VCNX	Vaccinex, Inc.
GLUE	Monte Rosa Therapeutics, Inc.
PHVS	Pharvaris N.V.
VINC	Vincerx Pharma, Inc.
TARA	Protara Therapeutics, Inc.
TRVI	Trevi Therapeutics, Inc.
MOLN	Molecular Partners AG
LYRA	Lyra Therapeutics, Inc.

RANI Ownership FAQ

Who Owns Rani Therapeutics?

Rani Therapeutics is owned by institutional shareholders (3.97%), insiders (43.90%), and public (52.14%). The largest institutional shareholder of Rani Therapeutics is VANGUARD GROUP INC (2.73% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.03% of total shares).

Who are the major institutional shareholders of Rani Therapeutics?

Rani Therapeutics's major institutional shareholders are VANGUARD GROUP INC, NAN FUNG GROUP HOLDINGS LTD, ALPHABET INC., UNITED SERVICES AUTOMOBILE ASSOCIATION, and GEODE CAPITAL MANAGEMENT, LLC. The top five shareholders own together 8.12% of the company's share outstanding.

How many Rani Therapeutics shareholders are there?

As of Jun 2024, there are 15 institutional shareholders of Rani Therapeutics.

What percentage of Rani Therapeutics is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC owns 709.83K shares of Rani Therapeutics, representing 2.73% of the company's total shares outstanding, valued at $2.7M (as of Jun 2024).

What percentage of Rani Therapeutics is owned by NAN FUNG GROUP HOLDINGS LTD?

As of Jun 2024, NAN FUNG GROUP HOLDINGS LTD holds 493.58K shares of Rani Therapeutics (RANI), compromising 1.90% of the company, valued at $1.88M.

What percentage of Rani Therapeutics is owned by ALPHABET INC?

ALPHABET INC is the third largest holder of Rani Therapeutics. The company owns 448.49K of the company's shares outstanding (worth $1.7M).